How OPTM is different
OPTM Healthcare has achieved a milestone in the history of pain care by introducing PAINDIAGNO C2A2R. It is a set of healthy pain diagnosis tests such as C-Reactive Protein Test (CRP), Creatine Phosphokinase test (CPK), Aldolase test and Anatomical tests. These tests help in diagnosing knee pain causes by checking inflammation levels and monitoring musculoskeletal damage. Any asymmetry which might have developed in the musculoskeletal system is diagnosed through Anatomical tests.OPTM healthcare has revolutionized the treatment protocol of knee osteoarthritis. Treating knee pain through an application of active photoconstituents, Apurba Ganguly’s approach to the treatment has been proven exemplary. The effectiveness of Ganguly’s treatment has been established through various pathological, anatomical and radiological tests by comparing pre- and post-treatment reports.Apurba Ganguly the chief researcher and founder of OPTM, research papers have been published in the International Journal of Phytomedicine.
The developments that he has established are revolutionizing the way of treatment in the following ways:
• Reversed muscle stiffness
• Effectively reduced inflammation of joints
• Rectified degeneration/calcification
• Reduced genu varum
• Increased gaps between bones/vertebrae
• Increased muscular strength
• Repaired muscular wasting
• Omitted the need of waist/knee joint belts and bed rest
These advancements have been commendable in the treatment of knee osteoarthritis.